Terms: = Lung cancer AND AFP, AFPD, FETA, HPAFP AND Treatment
162 results:
1. Clinical outcomes of percutaneous microwave ablation for pulmonary oligometastases from hepatocellular carcinoma: a retrospective, multicenter study.
Wang G; Wei Z; Wang F; Han X; Jia H; Zhao D; Li C; Liu L; Yang X; Ye X
Cancer Imaging; 2024 Mar; 24(1):34. PubMed ID: 38438879
[TBL] [Abstract] [Full Text] [Related]
2. Construction of web
Zhan G; Cao P; Peng H
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Oct; 48(10):1546-1560. PubMed ID: 38432884
[TBL] [Abstract] [Full Text] [Related]
3. Mono iso-centric VMAT planning for SBRT of multiple liver metastasis- A case report.
Barik BK; Kumari J; Sahoo DK; Majumdar SKD; Barik SK; Das DK; Parida DK
J Med Imaging Radiat Sci; 2023 Sep; 54(3):556-561. PubMed ID: 37455215
[TBL] [Abstract] [Full Text] [Related]
4. [Primary α-fetoprotein positive hepatoid adenocarcinoma of the lung: a case report].
Zhang K; Liu Q; Liu B; Lin D
Zhonghua Jie He He Hu Xi Za Zhi; 2023 Jul; 46(7):700-707. PubMed ID: 37402661
[TBL] [Abstract] [Full Text] [Related]
5. A case report of pulmonary hepatoid adenocarcinoma: promoting standardized diagnosis and treatment of the rare disease.
Xu K; Gao J; Feng L; Fang Y; Tang X
Front Immunol; 2023; 14():1203876. PubMed ID: 37292208
[TBL] [Abstract] [Full Text] [Related]
6. Conversion of primary liver cancer after targeted therapy for liver cancer combined with afp-targeted CAR T-cell therapy: a case report.
Wang Y; Zhao Y; Li M; Hou H; Jian Z; Li W; Li P; Ma F; Liu M; Liu H; Xue H
Front Immunol; 2023; 14():1180001. PubMed ID: 37256142
[TBL] [Abstract] [Full Text] [Related]
7. OHCCPredictor: an online risk stratification model for predicting survival duration of older patients with hepatocellular carcinoma.
Tan J; Yu Y; Lin X; He Y; Jin W; Qian H; Li Y; Xu X; Zhao Y; Ning J; Zhang Z; Chen J; Wu X
Hepatol Int; 2024 Apr; 18(2):550-567. PubMed ID: 37067674
[TBL] [Abstract] [Full Text] [Related]
8. Primary Pediatric Yolk Sac Tumor of Liver With lung Metastasis: An Unusual Presentation With Diagnosis Aided by LIN28 Immunohistochemistry.
Sekar MD; Pradeep I; Srinivas BH; Toi PC; Govindarajan K; Kayal S
Int J Surg Pathol; 2023 Dec; 31(8):1618-1625. PubMed ID: 37013352
[TBL] [Abstract] [Full Text] [Related]
9. Utility of combining PIVKA-II and afp in the surveillance and monitoring of hepatocellular carcinoma in the Asia-Pacific region.
Kim DY; Toan BN; Tan CK; Hasan I; Setiawan L; Yu ML; Izumi N; Huyen NN; Chow PK; Mohamed R; Chan SL; Tanwandee T; Lee TY; Hai TTN; Yang T; Lee WC; Chan HLY
Clin Mol Hepatol; 2023 Apr; 29(2):277-292. PubMed ID: 36710606
[TBL] [Abstract] [Full Text] [Related]
10. Alpha-Fetoprotein-Producing Esophageal Adenocarcinoma With Enteroblastic, Yolk Sac Tumor-Like, and Hepatoid Carcinoma Differentiation: A Rare Case and Literature Review.
Shore KT; Phelps KC; Balani J; Mitchell JM
Int J Surg Pathol; 2023 Aug; 31(5):884-889. PubMed ID: 36514283
[TBL] [Abstract] [Full Text] [Related]
11. Clinical application of irinotecan combined with first-line chemotherapeutics against pediatric hepatoblastoma with pulmonary metastasis.
Hu H; Zhang W; Li J; Li F; Wen Y; Mei Y; Huang D
Pak J Pharm Sci; 2022 Sep; 35(5):1301-1306. PubMed ID: 36451557
[TBL] [Abstract] [Full Text] [Related]
12. Risk factors and predictive nomograms for early death of patients with advanced hepatocellular carcinoma: a large retrospective study based on the SEER database.
Zhang H; Du X; Dong H; Xu W; Zhou P; Liu S; Qing X; Zhang Y; Yang M; Zhang Y
BMC Gastroenterol; 2022 Jul; 22(1):348. PubMed ID: 35854221
[TBL] [Abstract] [Full Text] [Related]
13. [Tumor Lysis Syndrome in a Patient with Germ Cell Tumor : A Case Report].
Koterazawa S; Masui K; Hama Y; Takahashi Y; Sawada A; Akamatsu S; Kobayashi T
Hinyokika Kiyo; 2022 Jun; 68(6):201-205. PubMed ID: 35850510
[TBL] [Abstract] [Full Text] [Related]
14. [A Case Report of afp-producing Primary lung Squamous Cell Carcinoma
with Significant Therapeutic Effect].
Chen Q; Wang Y; Zhang W; Wang C; Yin J; Guo Q
Zhongguo Fei Ai Za Zhi; 2022 Jan; 25(1):66-70. PubMed ID: 35078287
[TBL] [Abstract] [Full Text] [Related]
15. [Clinical analysis of testicular rhabdomyosarcoma].
Ye JF; Zhao L; Wang GL; Hong K; Ma LL
Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 53(6):1178-1182. PubMed ID: 34916701
[TBL] [Abstract] [Full Text] [Related]
16. Hepatoid Adenocarcinoma of the lung.
Li M; Fan Y; Lu H
Technol Cancer Res Treat; 2021; 20():15330338211057983. PubMed ID: 34816785
[TBL] [Abstract] [Full Text] [Related]
17. Regorafenib for Taiwanese patients with unresectable hepatocellular carcinoma after sorafenib failure: Impact of alpha-fetoprotein levels.
Hsu PY; Cheng TS; Chuang SC; Chang WT; Liang PC; Hsu CT; Wei YJ; Jang TY; Yeh ML; Huang CI; Lin YH; Wang CW; Hsieh MY; Hou NJ; Hsieh MH; Tsai YS; Ko YM; Lin CC; Chen KY; Dai CY; Lin ZY; Chen SC; Huang JF; Chuang WL; Huang CF; Yu ML
Cancer Med; 2022 Jan; 11(1):104-116. PubMed ID: 34786871
[TBL] [Abstract] [Full Text] [Related]
18. Clinical characteristics of Hepatoid adenocarcinoma of the lung: Four case reports and literature review.
Zhuansun Y; Bian L; Zhao Z; Du Y; Chen R; Lin L; Li J
Cancer Treat Res Commun; 2021; 29():100474. PubMed ID: 34656923
[TBL] [Abstract] [Full Text] [Related]
19. Differences in genetics and microenvironment of lung adenocarcinoma patients with or without TP53 mutation.
Zeng D; Hu Z; Yi Y; Valeria B; Shan G; Chen Z; Zhan C; Lin M; Lin Z; Wang Q
BMC Pulm Med; 2021 Oct; 21(1):316. PubMed ID: 34635074
[TBL] [Abstract] [Full Text] [Related]
20. Factors affecting the response to treatment and survival in hepatocellular carcinoma patients treated with transarterial radioembolisation: a single-centre experience.
Ekmekcioglu O; Tabakci ON; Bozdag Kaplan N; Hasanefendioglu Bayrak A; Battal M
Eur J Gastroenterol Hepatol; 2021 Jun; 33(6):926-931. PubMed ID: 33731592
[TBL] [Abstract] [Full Text] [Related]
[Next]
